BioSpace News Archive

The results of this interim analysis, a pre-planned evaluation of data from an ongoing trial, show that TAK-003 is associated with a reduction in the incidence of dengue in children and adolescents.

announced today that the company is scheduled to present an update on the company’s programs and progress at several upcoming scientific conferences: Society for Immunotherapy of Cancer 32nd Annual Meeting, Society for Neuro Oncology 22nd Annual Meeting and American Society of Hematology 59th Annual Meeting.

This Note was retired exclusively through a one-time conversion exercised by GS Capital on November 2, 2017 for 83,597,839 shares of the Company’s common stock.

The BlueCielo acquisition is the latest in a series of strategic acquisitions fueling Accruent’s growth.

Microscopic analysis of neurons in the prefrontal cortex from the treated FXS mice showed an improvement in dendritic spine morphology.

Schrodinger and ShanghaiTech University will embark on joint research projects to solve challenging scientific problems in molecular recognition of the human body that can lead to co-discoveries.

Increased revenue in the Bausch + Lomb/International segment by 1% compared to the third quarter of 2016.

Net loss for the three months ended September 30, 2017 (2017 Quarter) was $23.1 million, or $0.61 per share, as compared to a net loss of $7.9 million, or $0.21 per share, for the three months ended September 30, 2016 (2016 Quarter).

In this expanded role, Dr. Turkel will now be responsible global R&D as well as commercial strategy and development.

At the conclusion of the inspection, the FDA issued a Form 483 with four inspectional observations.